Virtu KCG Holdings’s Gilead Sciences GILD Stock Holding History

Virtu KCG Holdings’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-107,900	Closed	-$10.9M	–	3123
2015 Q4	$10.9M	Sell	107,900 -87,500	-45%	-$9.1M	0.19%	50
2015 Q3	$19.2M	Buy	195,400 +86,800	+80%	+$9.64M	0.31%	29
2015 Q2	$12.7M	Buy	108,600 +38,300	+54%	+$4.19M	0.23%	39
2015 Q1	$6.9M	Sell	70,300 -7,900	-10%	-$802K	0.14%	71
2014 Q4	$7.37M	Sell	78,200 -32,900	-30%	-$3.4M	0.12%	77
2014 Q3	$11.8M	Sell	111,100 -14,800	-12%	-$1.45M	0.23%	45
2014 Q2	$10.4M	Sell	125,900 -37,400	-23%	-$2.91M	0.16%	70
2014 Q1	$11.6M	Buy	163,300 +30,600	+23%	+$2.4M	0.14%	90
2013 Q4	$9.97M	Buy	132,700 +32,200	+32%	+$2.24M	0.11%	88
2013 Q3	$6.32M	Buy	+100,500	New	+$6.01M	0.08%	166

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu KCG Holdings's GILD Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Gilead Sciences (GILD) stake by 68% in Q2 2017, selling an estimated $2.66M and leaving 18,789 shares worth $1.33M. The position accounts for 0.04% of the portfolio, ranked #418.

Virtu KCG Holdings first reported a position in GILD in Q3 2013 and has held it in 15 quarters since. The position peaked at $12.7M in Q1 2015. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

Virtu KCG Holdings held 18,789 shares of Gilead Sciences worth $1.33M as of Q2 2017.
Virtu KCG Holdings sold 39,974 Gilead Sciences shares in Q2 2017, an estimated $2.66M.
Gilead Sciences made up 0.04% of Virtu KCG Holdings's portfolio in Q2 2017, its #418 holding.
Virtu KCG Holdings first reported a position in Gilead Sciences in Q3 2013 and has held it in 15 quarters since.
Virtu KCG Holdings's Gilead Sciences position peaked at $12.7M in Q1 2015.
1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.